The epidemiological transition of prostate cancer in Morocco: a critical analysis of the mortality-incidence gap (2018–2025)

Resumo

Prostate cancer (PCa) has emerged as the leading malignancy among Moroccan men. This brief communication analyses recent data (2018–2025) to outline the epidemiological transition of PCa in Morocco, characterised by a 77% surge in incidence over a 30-year trajectory. Despite improved diagnostic capabilities, the mortality-to-incidence ratio (MIR) (0.49) remains significantly higher than in high-Human Development Index (HDI) countries (< 0.20). This analysis highlights the urgent need for structured early-detection strategies to address the crisis of late-stage diagnosis in the North African context.